The Role of Depression Screening and Treatment in Achieving the UNAIDS 90-90-90 Goals in Sub-Saharan Africa.
Africa South of the Sahara
/ epidemiology
Antidepressive Agents
/ therapeutic use
Community Health Services
/ organization & administration
Continuity of Patient Care
Delivery of Health Care, Integrated
/ organization & administration
Depression
/ diagnosis
Depressive Disorder
/ epidemiology
Goals
HIV Infections
/ complications
Humans
Mass Screening
/ methods
Medication Adherence
Prevalence
Psychiatric Status Rating Scales
Treatment Outcome
United Nations
Depression
HIV/AIDS
Mental health disorders
Sub-Saharan Africa
UNAIDS 90–90–90
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
19
7
2019
medline:
29
10
2019
entrez:
19
7
2019
Statut:
ppublish
Résumé
Despite widespread HIV screening and treatment programs across sub-Saharan Africa, many countries are not on course to meet the Joint United Nations Program on HIV/AIDS 90-90-90 targets. As mental health disorders such as depression are prevalent among people living with HIV, investment in understanding and addressing comorbid depression is increasing. This manuscript aims to assess depression and HIV management in sub-Saharan Africa using a 90-90-90 lens through a discussion of: depression and the HIV care continuum; the state of depression screening and treatment; and innovations such as task-shifting strategies for depression management. Due to the lack of mental health infrastructure and human resources, task-shifting approaches that integrate mental health management into existing primary and community health programs are increasingly being piloted and adopted across the region. Greater integration of such mental health care task-shifting into HIV programs will be critical to realizing the 90-90-90 goals and ending the HIV epidemic.
Identifiants
pubmed: 31317365
doi: 10.1007/s10461-019-02593-7
pii: 10.1007/s10461-019-02593-7
pmc: PMC6773678
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-161Subventions
Organisme : FIC NIH HHS
ID : D43 TW010060
Pays : United States
Organisme : Project SOAR
ID : AID-OAA-140060
Références
PLoS One. 2010 Mar 04;5(3):e9538
pubmed: 20209059
J Affect Disord. 2012 Dec 20;143(1-3):208-13
pubmed: 22840467
AIDS Patient Care STDS. 2005 Dec;19(12):813-22
pubmed: 16375613
J Affect Disord. 2014 Apr;158:78-84
pubmed: 24655769
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Psychol Health Med. 2011 Oct;16(5):493-527
pubmed: 21809936
Afr J AIDS Res. 2009 Jun;8(2):123-33
pubmed: 25875564
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S54-67
pubmed: 25117961
Clin Infect Dis. 2018 Oct 15;67(9):1411-1418
pubmed: 29659757
BMC Psychiatry. 2011 Aug 22;11:138
pubmed: 21859455
Lancet HIV. 2015 May;2(5):e190-9
pubmed: 26423001
J Affect Disord. 2013 Sep 25;150(3):1041-7
pubmed: 23769290
J Health Psychol. 2018 May;23(6):776-787
pubmed: 27121977
Psychosomatics. 1993 Sep-Oct;34(5):432-9
pubmed: 7908136
PLoS One. 2012;7(11):e48671
pubmed: 23209556
Ann Behav Med. 2014 Jun;47(3):259-69
pubmed: 24234601
Soc Psychiatry Psychiatr Epidemiol. 2016 Jan;51(1):81-92
pubmed: 26433379
PLoS One. 2016 May 11;11(5):e0153132
pubmed: 27167852
BMC Public Health. 2011 Oct 26;11:828
pubmed: 22029430
Psychiatry Res. 2013 Dec 15;210(2):653-61
pubmed: 23972787
JAMA Psychiatry. 2018 Apr 1;75(4):379-385
pubmed: 29466531
Psychosom Med. 2008 Jun;70(5):539-45
pubmed: 18519880
Med Care. 1997 Nov;35(11):1164-70
pubmed: 9366895
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7
pubmed: 21857529
J Affect Disord. 2014;167:160-6
pubmed: 24972364
BMC Health Serv Res. 2018 Jul 31;18(1):593
pubmed: 30064418
Am J Psychiatry. 2007 Nov;164(11):1707-13
pubmed: 17974936
Health Policy Plan. 2015 Jul;30(6):791-803
pubmed: 25012090
BMC Psychiatry. 2014 Jun 30;14:188
pubmed: 24981595
Can J Psychiatry. 1992 Mar;37(2):109-15
pubmed: 1562954
AIDS Care. 2013;25(7):854-62
pubmed: 23383726
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
Psychol Med. 2014 Feb;44(3):657-66
pubmed: 23721658
Malawi Med J. 2011 Sep;23(3):85-8
pubmed: 23448002
Int J Psychiatry Med. 2012;43(2):105-17
pubmed: 22849034
BMC Pregnancy Childbirth. 2014 Dec 03;14:400
pubmed: 25467187
JAMA. 2016 Dec 27;316(24):2618-2626
pubmed: 28027368
J Int AIDS Soc. 2018 Mar;21(3):e25101
pubmed: 29603887
Int J Soc Psychiatry. 2014 Mar;60(2):155-61
pubmed: 23399989
Afr J AIDS Res. 2014;13(4):331-8
pubmed: 25555099
AIDS. 2003;17 Suppl 4:S3-11
pubmed: 15080170
Am J Epidemiol. 2017 May 15;185(10):869-878
pubmed: 28430844
Arch Womens Ment Health. 2010 Jun;13(3):201-6
pubmed: 19760051
PLoS One. 2015 Oct 15;10(10):e0140001
pubmed: 26469186
AIDS Behav. 2012 Nov;16(8):2226-35
pubmed: 22451351
Clin Infect Dis. 2018 Oct 30;67(10):1575-1581
pubmed: 29618020
PLoS One. 2017 Aug 4;12(8):e0181960
pubmed: 28783739
Trop Med Int Health. 2015 Jul;20(7):903-13
pubmed: 25754063
Psychiatr Q. 2008 Mar;79(1):43-53
pubmed: 18095166
Ann Intern Med. 2000 Jul 4;133(1):21-30
pubmed: 10877736
BMJ Open. 2017 Dec 28;7(12):e017408
pubmed: 29288177
AIDS Behav. 2018 Jan;22(1):86-101
pubmed: 28063075
AIDS Behav. 2012 Nov;16(8):2101-18
pubmed: 22116638
Afr J AIDS Res. 2011 Jun;10(2):101-22
pubmed: 25859733
Psychol Health. 2019 Jul;34(7):796-810
pubmed: 30773914
J Affect Disord. 2013 Nov;151(2):439-48
pubmed: 23890669
BMC Psychiatry. 2019 Feb 27;19(1):81
pubmed: 30813922
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):432-8
pubmed: 15764960
J Int AIDS Soc. 2014 Jul 30;17:18965
pubmed: 25085002
J Health Psychol. 2017 Sep;22(10):1265-1276
pubmed: 26893295